Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus

被引:102
作者
Kauma, SW
Huff, TF
Hayes, N
Nilkaeo, A
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Obstet Gynecol, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Med Coll Virginia, Dept Microbiol Immunol, Richmond, VA 23298 USA
关键词
D O I
10.1210/jc.84.6.2188
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fas ligand (FasL) is a peptide that plays an important immunoregulatory role in limiting the host immune response. Several studies have shown that the expression of Fast in the anterior chamber of the eye and the testis allows these tissues to be immunoprivileged sites. Immunotolerance is achieved by binding of Fast to its receptor (Fas) on activated immune cells, which results in cell apoptosis. To determine whether Fast has a role in maternal immune tolerance to the fetus, we looked for the expression of Fast in the human placenta. Immunoperoxidase staining localized Fast to both syncytiotrophoblast and cytotrophoblast in placental villi and chorionic extravillous trophoblast. Western analysis demonstrated Fast in placental villi and a human first-trimester trophoblast cell line (ED27). In contrast, Fas was colocalized to CD45 (leukocyte common antigen) positive cells found in maternal decidua. When isolated peripheral blood lymphocytes were induced to express Fas with phytohemagglutinin (PHA) and interleukin-2 (IL-2) and then cocultured with trophoblast, 30% of the lymphocytes underwent apoptosis, as determined by the in situ death (TUNEL) assay. Neutralizing antibodies to Fast inhibited apoptosis by 40% in these studies. In contrast, activated lymphocytes cocultured with non-FasL-expressing fibroblasts or unactivated non-Fas-expressing lymphocytes cocultured with ED27 trophoblast showed little evidence of apoptosis. These findings suggest that Fast expressed by fetal trophoblast cells can induce apoptosis in activated lymphocytes there by providing a mechanism for maternal immune tolerance to the fetus.
引用
收藏
页码:2188 / 2194
页数:7
相关论文
共 32 条
[1]   Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells [J].
Bamberger, AM ;
Schulte, HM ;
Thuneke, I ;
Erdmann, I ;
Bamberger, CM ;
Asa, SL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (09) :3173-3175
[2]   A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION [J].
BELLGRAU, D ;
GOLD, D ;
SELAWRY, H ;
MOORE, J ;
FRANZUSOFF, A ;
DUKE, RC .
NATURE, 1995, 377 (6550) :630-632
[3]   ANTIGEN EXPRESSION BY TROPHOBLAST POPULATIONS IN THE HUMAN-PLACENTA AND THEIR POSSIBLE IMMUNOBIOLOGICAL RELEVANCE [J].
BULMER, JN ;
JOHNSON, PM .
PLACENTA, 1985, 6 (02) :127-140
[4]  
BULMER JN, 1985, IMMUNOLOGY, V55, P35
[5]   IMPLANTATION AND THE PLACENTA - KEY PIECES OF THE DEVELOPMENT PUZZLE [J].
CROSS, JC ;
WERB, Z ;
FISHER, SJ .
SCIENCE, 1994, 266 (5190) :1508-1518
[6]   ANTI-TROPHOBLAST ANTIBODY-RESPONSES DURING NORMAL HUMAN-PREGNANCY [J].
DAVIES, M ;
BROWNE, CM .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1985, 7 (04) :285-297
[7]  
FOEGH ML, 1988, TRANSPLANT P, V20, P1158
[8]  
GILL TJ, 1987, IMMUNOREGULATION FET, P3
[9]   FAS LIGAND-INDUCED APOPTOSIS AS A MECHANISM OF IMMUNE PRIVILEGE [J].
GRIFFITH, TS ;
BRUNNER, T ;
FLETCHER, SM ;
GREEN, DR ;
FERGUSON, TA .
SCIENCE, 1995, 270 (5239) :1189-1192
[10]  
HALLORAN P, 1989, TRANSPL P, V21, P21